Supply of unlicensed PERT preparations
According to the Shortage of Pancreatic enzyme replacement therapy (PERT) National Patient Safety Alert (NPSA) published on 18 December 2024, Creon® will remain in limited supply until 2026 and alternatives such as Nutrizym® 22 capsules and Pancrex V® capsules and powder are intermittently available but are unable to fully cover the gap in supply. One of the [...]
The post Supply of unlicensed PERT preparations appeared first on Community Pharmacy England.
Recent Comments